Atezolizumab for the treatment of advanced recurrent basal cell carcinoma and urothelial carcinoma of bladder: a case report

por Küronya, Zsófia, Danyi, Tímea, Balatoni, Tímea, Liszkay, Gabriella, Tóth, Erika, Biró, Krisztina, Géczi, Lajos
Publicado 2022

Therapeutic and Adverse Effect of Anti-PD1 Immunotherapy in Melanoma: A Retrospective, Single-Institute Study of 222 Patients

por Eikenes, Grethe, Liszkay, Gabriella, Balatoni, Tímea, Czirbesz, Kata, Hunyadi, Karen, Kozéki, Zsófia, Kispál, Mihály Tamás, Baranyai, Fanni, Danyi, Tímea, Bőcs, Katalin, Kenessey, István
Publicado 2023